SEARCH

SEARCH BY CITATION

References

  • 1
    Carmona L, Villaverde V, Hernández-García C, Ballina J, Gabriel R, Laffon A; EPISER Study Group (2002) The prevalence of rheumatoid arthritis in the general population of Spain. Rheumatology (Oxford) 41(1), 8895.
  • 2
    Symmons D, Mathers C, Pfleger B (2002) The global burden of rheumatoid arthritis in the year 2000. Documentation for GBD 2000 project. WHO, Geneva.
  • 3
    Lajas C, Abasolo L, Bellajdel B et al. (2003) Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study. Arthritis Rheum 49(1), 6470.
  • 4
    Lukas C, Combe B, Ravaud P, Sibilia J, Landew R, van der Heijde D (2011) Favorable effect of very early disease-modifying antirheumatic drug treatment on radiographic progression in early inflammatory arthritis: data from the Étude et Suivi des polyarthrites indifférenciées récentes (study and follow-up of early undifferentiated polyarthritis). Arthritis Rheum 63, 180411.
  • 5
    Smolen JS, Landewé R, Breedveld FC et al. (2010) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 69, 96475.
  • 6
    Davatchi F, Akbarian M, Shahram F, Najdi A, Gharibdoost F, Jamshidi AR (2006) DMARD combination therapy in rheumatoid arthritis: 5-year follow-up results in a daily practice setting. APLAR J Rheumatol 9, 603.
  • 7
    National Collaborating Centre for Chronic Conditions. Rheumatoid Arthritis: National Clinical Guideline for Management and Treatment in Adults. Royal College of Physicians, London, February 2009. Available at: http://guidance.nice.org.uk/nicemedia/live/12131/43326/43326.pdf. Accessed 29 June 2012.
  • 8
    Singh JA, Furst DE, Bharat A et al. (2012) 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 64, 62539.
  • 9
    Grigor C, Capell H, Stirling A et al. (2004) Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 364(9430), 2639.
  • 10
    Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF et al. (2007) Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial. Ann Intern Med 146, 40615.
  • 11
    Verstappen SM, Jacobs JW, van der Veen MJ et al. (2007) Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis 66, 14439.
  • 12
    Fransen J, Moens HB, Speyer I, van Riel PL (2005) Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial. Ann Rheum Dis 64, 12948.
  • 13
    Dowman B, Campbell RM, Zgaga L, Adeloye D, Chan KY (2012) Estimating the burden of rheumatoid arthritis in Africa: a systematic analysis. J Glob Health 2, 20406.
  • 14
    Chaaya M, Slim ZN, Habib RR et al. (2012) High burden of rheumatic diseases in Lebanon: a COPCORD study. Int J Rheum Dis 15, 13643.
  • 15
    Davatchi F, Jamshidi AR, Banihashemi AT et al. (2008) WHO-ILAR COPCORD study (stage 1, urban study) in Iran. J Rheumatol 35, 1384.
  • 16
    Davatchi F, Tehrani Banihashemi A, Gholami J et al. (2009) The prevalence of musculoskeletal complaints in a rural area in Iran: a WHO-ILAR COPCORD study (stage 1, rural study) in Iran. Clin Rheumatol 28, 126774.
  • 17
    Solomon A, Christian BF, Dessein PH, Stanwix AE (2005) The need for tighter rheumatoid arthritis control in a South African public health care center. Semin Arthritis Rheum 35, 12231.
  • 18
    Benitha R, Tikly M (2007) Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol 26(1), 249.
  • 19
    Badsha H, Kong KO, Tak PP (2008) Rheumatoid arthritis in the United Arab Emirates. Clin Rheumatol 27, 73942.
  • 20
    Baddoura R, Haddad S, Awada H et al. (2006) Severity of rheumatoid arthritis: the SEVERA study. Clin Rheumatol 25, 7004.
  • 21
    Al-Arfaj AS, Al-Boukai AA (2005) Patterns of radiographic changes in hands and feet of rheumatoid arthritis in Saudi Arabia. Saudi Med J 26, 10657.
  • 22
    Attar SM, Al-Ghamdi A (2010) Radiological changes in rheumatoid arthritis patients at a teaching hospital in Saudi Arabia. East Mediterr Health J 16, 9537.
  • 23
    Al-Salem IH, Al-Awadhi AM (2004) The expression of rheumatoid arthritis in Kuwaiti patients in an outpatient hospital-based practice. Med Princ Pract 13(1), 4750.
  • 24
    Al-Temimi F (2010) The spectrum of rheumatoid arthritis in patients attending rheumatology clinic in Nizwa hospital-Oman. Oman Med J 25, 1849.
  • 25
    Amador-Patarroyo MJ, Rodriguez-Rodriguez A, Montoya-Ortiz G (2012) How does age at onset influence the outcome of autoimmune diseases? Autoimmune Dis 2012, 251730.
  • 26
    Spinel-Bejarano N, Quintana G, Heredia R et al. (2013) Comparative study of elderly-onset rheumatoid arthritis and young-onset rheumatoid arthritis in a Colombian population: clinical, laboratory and HLA-DRB1 findings. Clin Exp Rheumatol 31(1), 406.
  • 27
    Dejaco C, Duftner C, Wipfler-Freissmuth E, Weiss H, Schneider T, Schirmer M (2013) Elderly- versus younger-onset rheumatoid arthritis: higher levels of ultrasound-detected inflammation despite comparable clinical disease activity. Arthritis Care Res (Hoboken) 65, 3048.
  • 28
    El-Labban AS, Omar HA, El-Shereif RR, Ali F, El-Mansoury TM (2010) Pattern of young and old onset rheumatoid arthritis (YORA and EORA) among a group of egyptian patients with rheumatoid arthritis. Clin Med Insights Arthritis Musculoskelet Disord 3, 2531.
  • 29
    El Zorkany B, Alwahshi HA, Hammoudeh M et al. (2013) Suboptimal management of rheumatoid arthritis in the Middle East and Africa: could the EULAR recommendations be the start of a solution? Clin Rheumatol 32, 1519.
  • 30
    Michaud K, Wolfe F (2007) Comorbidities in rheumatoid arthritis. Best Pract Res Clin Rheumatol 21, 885906.
  • 31
    Sliem H, Nasr G (2010) Change of the aortic elasticity in rheumatoid arthritis: relationship to associated cardiovascular risk factors. J Cardiovasc Dis Res 1, 1105.
  • 32
    El Miedany Y, El Gaafary M, El Aroussy N, Youssef S, Ahmed I (2012) Sexual dysfunction in rheumatoid arthritis patients: arthritis and beyond. Clin Rheumatol 31(4), 6016.
  • 33
    Ibn Yacoub Y, Amine B, Laatiris A, Hajjaj-Hassouni N (2012) Health-related quality of life in Moroccan patients with rheumatoid arthritis. Clin Rheumatol 31, 14717.
  • 34
    Rkain H, Allali F, Jroundi I, Hajjaj-Hassouni N (2006) Socioeconomic impact of rheumatoid arthritis in Morocco. Joint Bone Spine 73, 27883.
  • 35
    Dessein PH, Norton GR, Joffe BI, Abdool-Carrim AT, Woodiwiss AJ, Solomon A (2013) Metabolic cardiovascular risk burden and atherosclerosis in African black and Caucasian women with rheumatoid arthritis: a cross-sectional study. Clin Exp Rheumatol 31(1), 5361.
  • 36
    Shilbayeh S (2003) Prevalence of osteoporosis and its reproductive risk factors among Jordanian women: a cross-sectional study. Osteoporos Int 14, 92940.
  • 37
    Noorwali AA (2004) Bone density in rheumatoid arthritis. Saudi Med J 25(6), 7669.
  • 38
    Gough AK, Lilley J, Eyre S, Holder RL, Emery P (1994) Generalised bone loss in patients with early rheumatoid arthritis. Lancet 344(8914), 237.
  • 39
    Haugeberg G, Lodder MC, Lems WF et al. (2004) Hand cortical bone mass and its associations with radiographic joint damage and fractures in 50–70 year old female patients with rheumatoid arthritis: cross sectional Oslo-Truro-Amsterdam (OSTRA) collaborative study. Ann Rheum Dis 63, 13314.
  • 40
    Adelowo OO, Ojo O, Oduenyi I, Okwara CC (2010) Rheumatoid arthritis among Nigerians: the first 200 patients from a rheumatology clinic. Clin Rheumatol 29, 5937.
  • 41
    Ndongo S, Lekpa FK, Ka MM, Ndiaye N, Diop TM (2009) Presentation and severity of rheumatoid arthritis at diagnosis in Senegal. Rheumatology (Oxford) 48, 11113.
  • 42
    Benbouazza K, Benchekroun B, Rkain H et al. (2011) Profile and course of early rheumatoid arthritis in Morocco: a two-year follow-up study. BMC Musculoskelet Disord 12, 266.
  • 43
    Sokka T, Kautiainen H, Pincus T et al. (2009) Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database. Ann Rheum Dis 68, 166672.
  • 44
    Oyoo O, Moots RJ, Ganda B (2012) Stepping into the state of rheumatology in East Africa. Rheumatology (Oxford) 51, 13456.
  • 45
    Abourazzak F, El Mansouri L, Huchet D et al. (2009) Long-term effects of therapeutic education for patients with rheumatoid arthritis. Joint Bone Spine 76, 64853.
  • 46
    Riemsma RP, Taal E, Kirwan JR, Rasker JJ (2004) Systematic review of rheumatoid arthritis patient education. Arthritis Rheum 51, 104559.
  • 47
    Zafar S, Badsha H, Mofti A et al. (2011) Efforts to increase public awareness may result in more timely diagnosis of rheumatoid arthritis. J Clin Rheumatol 18, 27982.
  • 48
    Barlow JH, Turner AP, Wright CC (2000) A randomized controlled study of the Arthritis Self-Management Programme in the UK. Health Educ Res 15, 66580.